Pharmachronicles

Top Menu

  • Home
  • Our Blog
  • Contact Us

Main Menu

  • Home Page
  • STUDENTS ZONE
  • Syllabus
  • Seminars & conferences
  • Online classes
    • Register
Sign in / Join

Login

Welcome! Login in to your account
Lost your password?

Lost Password

Back to login
  • Home
  • Our Blog
  • Contact Us

Pharmachronicles

Header Banner

Pharmachronicles

  • Home Page
  • STUDENTS ZONE
  • Syllabus
  • Seminars & conferences
  • Online classes
    • Register
  • UGC-Cancelled-List of journals

  • NAAC stops accepting applications for accreditation from pharmacy colleges

  • Pursuing MPhil/PhD while working as a teacher will effect experience: UGC

  • Public notice by government of india ministry of health and family welfare

BLOGS
Home›BLOGS›Opioid Addiction Treatment Device approved by FDA

Opioid Addiction Treatment Device approved by FDA

By admin
December 2, 2017
744
0
Share:

The U.S. Food and Drug Administration (FDA) announced on November 15 the approval of a device called the Neuro-Stim System Bridge (NSS-2 Bridge), which is meant to help reduce the symptoms of opioid withdrawal. It’s the first medical device of its kind that’s been given the FDA’s blessing.

The NSS-2 Bridge is a relatively simple device that attaches to the skin behind the ear, where it uses a chip to transmit controlled electrical pulses to stimulate four cranial nerves in the part of the brain that’s associated with processing pain information.

Marketed by Indiana-based Innovative Health Solutions, the Bridge was previously cleared to treat chronic and acute pain in 2014. The new approval “expands the use of the device as an aid to reduce the symptoms of opioid withdrawal,” according to the FDA, though it will only be available by prescription. It is rather pricey though, with previous Bridge treatments costing between $600 and $800.

There’s little to suggest how broadly effective this treatment could be, however. The FDA granted permission for the device after reviewing data from a clinical study that worked with “73 patients undergoing opioid physical withdrawal,” the announcement says. The trials showed that 64 out of these 73 patients, or 88 percent, successfully transitioned away from opioids after five days of using the Bridge. There is clearly efficacy here, although the number of respondents could’ve been higher.

Towards Better Treatment

An opioid addiction treatment device is still welcome news, particularly since abusive use of opioids has continued to be menace in American society. The National Institutes on Drug Abuse reports that some 90 Americans die every day from opioid overdose, and a lot of this comes from misuse of prescription pain relievers, as well as overdose from heroin and synthetic opioids like fentanyl.

Meanwhile, the Centers for Disease Control and Prevention (CDC) notes that prescription opioid misuse costs the U.S. around $78.5 billion a year, from healthcare expenses, loss productivity, addiction treatment and from criminal justice involvement.

“Given the scope of the epidemic of opioid addiction, we need to find innovative new ways to help those currently addicted live lives of sobriety with the assistance of medically assisted treatment,” FDA Commissioner Scott Gottlieb said in the press announcement. “While we continue to pursue better medicines for the treatment of opioid use disorder, we also need to look to devices that can assist in this therapy.”

Gottlieb noted that there are already three approved drugs for treating opioid addiction, but the FDA remains “committed to supporting the development of novel treatments, both drugs and devices, that can be used to address opioid dependence or addiction, as well as new, non-addictive treatments for pain that can serve as alternatives to opioids.”

Indeed, there are a number of other efforts to combat the opioid epidemic, including an app that tracks opioid overdoses all over the U.S. in real-time. Others are looking to artificial intelligence (AI) to find solutions, while some are testing devices that could replace non-addictive painkillers. In order to put an end to the opioid crisis, it’s also necessary to improve on our knowledge of how drug-seeking behavior works.

TagsCDCfdaOpioid
Previous Article

human embryonic Stem Cells can fix blindness

Next Article

US FDA approves first biosimilar for certain ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

admin

Related articles More from author

  • Trials

    Progression of rare connective tissue tumor controlled by targeted therapy

    December 26, 2018
    By Ramoju kishore kumar
  • Uncategorized

    FDA approve new robotically-assisted surgical device for adult patients

    October 21, 2017
    By admin
  • BLOGS

    FDA approves pill with sensor

    November 15, 2017
    By admin
  • Medical & Health

    Cancer Vaccination Rates Rising Among U.S. Teens From Year To Year

    August 26, 2018
    By Ramoju kishore kumar
  • BLOGS

    Can biotin manipulate lab test

    August 28, 2018
    By admin
  • BLOGS

    FDA is carefully evaluating prescription opioid medications approved to treat cough in children

    July 16, 2015
    By admin

Leave a reply Cancel reply

You may interested

  • Medical & HealthMedical research

    MENOPAUSAL HORMONAL REPLACEMENT THERAPY

  • BLOGS

    Treating Hereditary blindness by gene therapy will be a revolution in medical field

  • FDA AlertsMedical & HealthMedical research

    FDA approves a new clinical trial for non-healing wounds.

  • LATEST REVIEWS

  • TOP REVIEWS

  • Pharmacists are not eligible for certificate program of community health

    0
  • A New Class of Antimicrobials Has Just Been Found in Human Breast Milk Fresh super ...

    0

Timeline

  • May 24, 2021

    LIST OF SCOPUS INDEXED JOURNALS APRIL 2021

  • October 20, 2020

    List of UGC Approved journals 2020

  • June 8, 2020

    Brain Tumor Day -8th June – Endoscopic surgery: An innovative approach to treat brain tumour

  • June 4, 2020

    UGC-Cancelled-List of journals

  • June 1, 2020

    Saroj Group Of Hospitals restarts its complete operations – see major footfall in OPD consultation

Latest Comments

  • Sowmya V
    on
    December 13, 2019
    Nice keep it up

    Blood Test Might Predict Pregnancy Due Date and Preterm Birth

Find us on Facebook

Follow Us on Instagram

logo

Dui viverra Faucibus aliquet quis phasellus accumsan. Donec et facilisis sociosqu sed tortor elit eu aliquid turpis ridiculus.

Fly, shall, have greater fifth spirit midst under from stars thing is, had creepeth multiply kind. Man may they’re meat years have third bring replenish air two light deep fill.

About us

  • Dr.N.Sriram, Founder CEO, Pharmachronicles, HITS college of Pharmacy, Ghatkesar, Hyderabad, India
  • 9704361947
  • pharmachronicles@gmail.com
  • Recent

  • Popular

  • Comments

  • LIST OF SCOPUS INDEXED JOURNALS APRIL 2021

    By admin
    May 24, 2021
  • List of UGC Approved journals 2020

    By admin
    October 20, 2020
  • Brain Tumor Day -8th June – Endoscopic surgery: An innovative approach to treat brain tumour

    By Sriram Nagarajan
    June 8, 2020
  • UGC-Cancelled-List of journals

    By admin
    June 4, 2020
  • Blood Test Might Predict Pregnancy Due Date and Preterm Birth

    By Sundari srinidhi
    December 12, 2019
  • FDA is carefully evaluating prescription opioid medications approved to treat cough in children

    By admin
    July 16, 2015
  • Record Numbers of FDA‑Approved Drugs: Recent Trends

    By admin
    July 16, 2015
  • There make for Sixth that multiply blessed two divide creeping

    By admin
    July 16, 2015
  • Sowmya V
    on
    December 13, 2019

    Blood Test Might Predict Pregnancy Due Date and Preterm Birth

    Nice keep it up

Photostream

    Follow us

    • Contact
    • STUDENTS ZONE
    • About Us
    © Copyright Pharmachronicles. All rights reserved.